# Pandeia Therapeutics Limited

## Details

- **Company number:** [11463856](https://find-and-update.company-information.service.gov.uk/company/11463856)
- **Status:** Active
- **Type:** Private limited company
- **Incorporated:** 13 Jul 2018
- **Registered office:** THE CAMBRIDGE PARTNERSHIP THE DOROTHY HODGKIN BLDG BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3FH
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Acadia Pharmaceuticals Inc. | ownership-of-shares-75-to-100-percent | 22 Dec 2022 |  |
| Medicxi Ventures I Lp | ownership-of-shares-75-to-100-percent | 20 Sep 2019 | 22 Dec 2022 |
| Dr Timothy Schulz-Utermoehl | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 13 Jul 2018 | 20 Sep 2019 |
| Mr Martin Quibell | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 5 Mar 2019 | 5 Mar 2019 |
| Dr Fraser Murray | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 5 Mar 2019 | 5 Mar 2019 |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | £37,517 | £66,255 | 1 |
| 31 Dec 2024 | -£3,214,073 | £222,751 | 1 |
| 31 Dec 2023 | -£1,295,422 | £178,617 | 3 |
| 31 Aug 2022 | - | £796,269 | 3 |
| 31 Dec 2021 | - | £1,525,884 | 3 |
| 31 Dec 2020 | - | £364,357 | 1 |
| 31 Dec 2019 | - | £1,385,926 | 1 |